Report Detail

Pharma & Healthcare Global Erectile Dysfunction Treatment Drugs Market Size, Status and Forecast 2019-2025

  • RnM3791836
  • |
  • 30 September, 2019
  • |
  • Global
  • |
  • 99 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Erectile dysfunction is a very common sexual problem affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance and obesity. The incidence of erectile dysfunction is also proportionate to ageing, along with being associated with certain risk factors such as usage of tobacco and alcohol, certain medications and medical treatment, injuries and psychological conditions.
In 2018, the global Erectile Dysfunction Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Erectile Dysfunction Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Erectile Dysfunction Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Pfizer Inc.
Dong-A Pharmaceutical Co. Ltd
Vivus, Inc.
Meda Pharmaceuticals
Bayer AG
Johnson & Johnson Services
Apricus Biosciences
Eli Lilly

Market segment by Type, the product can be split into
Phosphodiesterase Type 5 Inhibitors
Prostaglandin E1

Market segment by Application, split into
Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Erectile Dysfunction Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Erectile Dysfunction Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Erectile Dysfunction Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Phosphodiesterase Type 5 Inhibitors
      • 1.4.3 Prostaglandin E1
    • 1.5 Market by Application
      • 1.5.1 Global Erectile Dysfunction Treatment Drugs Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Erectile Dysfunction Treatment Drugs Market Size
    • 2.2 Erectile Dysfunction Treatment Drugs Growth Trends by Regions
      • 2.2.1 Erectile Dysfunction Treatment Drugs Market Size by Regions (2019-2025)
      • 2.2.2 Erectile Dysfunction Treatment Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Erectile Dysfunction Treatment Drugs Market Size by by Players
      • 3.1.1 Global Erectile Dysfunction Treatment Drugs Revenue by by Players (2014-2019)
      • 3.1.2 Global Erectile Dysfunction Treatment Drugs Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Erectile Dysfunction Treatment Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Erectile Dysfunction Treatment Drugs Key Players Head office and Area Served
    • 3.3 Key Players Erectile Dysfunction Treatment Drugs Product/Solution/Service
    • 3.4 Date of Enter into Erectile Dysfunction Treatment Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Erectile Dysfunction Treatment Drugs Market Size by Type (2014-2019)
    • 4.2 Global Erectile Dysfunction Treatment Drugs Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Erectile Dysfunction Treatment Drugs Market Size (2014-2019)
    • 5.2 Erectile Dysfunction Treatment Drugs Key Players in North America
    • 5.3 North America Erectile Dysfunction Treatment Drugs Market Size by Type
    • 5.4 North America Erectile Dysfunction Treatment Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Erectile Dysfunction Treatment Drugs Market Size (2014-2019)
    • 6.2 Erectile Dysfunction Treatment Drugs Key Players in Europe
    • 6.3 Europe Erectile Dysfunction Treatment Drugs Market Size by Type
    • 6.4 Europe Erectile Dysfunction Treatment Drugs Market Size by Application

    7 China

    • 7.1 China Erectile Dysfunction Treatment Drugs Market Size (2014-2019)
    • 7.2 Erectile Dysfunction Treatment Drugs Key Players in China
    • 7.3 China Erectile Dysfunction Treatment Drugs Market Size by Type
    • 7.4 China Erectile Dysfunction Treatment Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Erectile Dysfunction Treatment Drugs Market Size (2014-2019)
    • 8.2 Erectile Dysfunction Treatment Drugs Key Players in Japan
    • 8.3 Japan Erectile Dysfunction Treatment Drugs Market Size by Type
    • 8.4 Japan Erectile Dysfunction Treatment Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Erectile Dysfunction Treatment Drugs Market Size (2014-2019)
    • 9.2 Erectile Dysfunction Treatment Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Erectile Dysfunction Treatment Drugs Market Size by Type
    • 9.4 Southeast Asia Erectile Dysfunction Treatment Drugs Market Size by Application

    10 India

    • 10.1 India Erectile Dysfunction Treatment Drugs Market Size (2014-2019)
    • 10.2 Erectile Dysfunction Treatment Drugs Key Players in India
    • 10.3 India Erectile Dysfunction Treatment Drugs Market Size by Type
    • 10.4 India Erectile Dysfunction Treatment Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Erectile Dysfunction Treatment Drugs Market Size (2014-2019)
    • 11.2 Erectile Dysfunction Treatment Drugs Key Players in Central & South America
    • 11.3 Central & South America Erectile Dysfunction Treatment Drugs Market Size by Type
    • 11.4 Central & South America Erectile Dysfunction Treatment Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer Inc.
      • 12.1.1 Pfizer Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Erectile Dysfunction Treatment Drugs Introduction
      • 12.1.4 Pfizer Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2014-2019))
      • 12.1.5 Pfizer Inc. Recent Development
    • 12.2 Dong-A Pharmaceutical Co. Ltd
      • 12.2.1 Dong-A Pharmaceutical Co. Ltd Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Erectile Dysfunction Treatment Drugs Introduction
      • 12.2.4 Dong-A Pharmaceutical Co. Ltd Revenue in Erectile Dysfunction Treatment Drugs Business (2014-2019)
      • 12.2.5 Dong-A Pharmaceutical Co. Ltd Recent Development
    • 12.3 Vivus, Inc.
      • 12.3.1 Vivus, Inc. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Erectile Dysfunction Treatment Drugs Introduction
      • 12.3.4 Vivus, Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2014-2019)
      • 12.3.5 Vivus, Inc. Recent Development
    • 12.4 Meda Pharmaceuticals
      • 12.4.1 Meda Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Erectile Dysfunction Treatment Drugs Introduction
      • 12.4.4 Meda Pharmaceuticals Revenue in Erectile Dysfunction Treatment Drugs Business (2014-2019)
      • 12.4.5 Meda Pharmaceuticals Recent Development
    • 12.5 Bayer AG
      • 12.5.1 Bayer AG Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Erectile Dysfunction Treatment Drugs Introduction
      • 12.5.4 Bayer AG Revenue in Erectile Dysfunction Treatment Drugs Business (2014-2019)
      • 12.5.5 Bayer AG Recent Development
    • 12.6 Johnson & Johnson Services
      • 12.6.1 Johnson & Johnson Services Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Erectile Dysfunction Treatment Drugs Introduction
      • 12.6.4 Johnson & Johnson Services Revenue in Erectile Dysfunction Treatment Drugs Business (2014-2019)
      • 12.6.5 Johnson & Johnson Services Recent Development
    • 12.7 Apricus Biosciences
      • 12.7.1 Apricus Biosciences Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Erectile Dysfunction Treatment Drugs Introduction
      • 12.7.4 Apricus Biosciences Revenue in Erectile Dysfunction Treatment Drugs Business (2014-2019)
      • 12.7.5 Apricus Biosciences Recent Development
    • 12.8 Eli Lilly
      • 12.8.1 Eli Lilly Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Erectile Dysfunction Treatment Drugs Introduction
      • 12.8.4 Eli Lilly Revenue in Erectile Dysfunction Treatment Drugs Business (2014-2019)
      • 12.8.5 Eli Lilly Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Erectile Dysfunction Treatment Drugs. Industry analysis & Market Report on Erectile Dysfunction Treatment Drugs is a syndicated market report, published as Global Erectile Dysfunction Treatment Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Erectile Dysfunction Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,088.80
      4,633.20
      6,177.60
      3,603.60
      5,405.40
      7,207.20
      590,031.00
      885,046.50
      1,180,062.00
      325,143.00
      487,714.50
      650,286.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report